@jasminenephro.bsky.social
Academic Nephrologist at PGI Chandigarh🇮🇳Social media editor @NDT/CKJ #NephSky Insta account https://www.instagram.com/jazz_doc21?igsh=MXc4OTQ1aDRxdTR6
🥸Kidney stones that require metabolic evaluation of patient
academic.oup.com/pmj/article/...
🧬Complement Pathways and Regulators in Kidney Ds
doi.org/10.1093/ndt/...
@hjanders.bsky.social
😩Gout Management in CKD
www.ajkd.org/article/S027...
@ajkd.bsky.social
Claim your travel grant for #ISNCON25 ‼️
Submit your abstract here: isn-india.org/isn_registra...
@jasminenephro.bsky.social
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@arvindcanchi.bsky.social
🫘Non invasive biomarkers of Rejection
pubmed.ncbi.nlm.nih.gov/39419272/
@ajkd.bsky.social
🫘Renal Amyloidosis
academic.oup.com/ndt/article-...
@hjanders.bsky.social
💊🫘Drugs to prevent CKD Progression
doi.org/10.1093/ndt/...
@hjanders.bsky.social
🌟Beyond Testing—IgAN Trials Unveiled!-Must Read🌟
From #Sparsentan to #Iptacopan, innovative non-immunomodulatory & immunomodulatory therapies are transforming IgAN care!🎯
🔬 Excellent Trial insights by @Melgreux
📖 via @KidneyKolumns Jan25
#Nephrology #IgAN #ClinicalTrials
🫘🎯Light chain Amyloidosis
😬Kidneys 🫘 and heart most commonly involved
🎯Mostly nephrotic range proteinuria
@nejm.org
www.nejm.org/doi/full/10....
When should the nephrologist think about genetics in patients with glomerular diseases?
doi.org/10.1093/ckj/...
👍New Lupus Nephritis guidelines
#ACR2024
🤘Major change-Triple therapy for induction ✅
🦠🫘Approach to BKV in kidney transplant recipients
doi.org/10.1093/ndt/...
@hjanders.bsky.social
SGLT2i/MRA/GLP1 agonist are our new DMANDs 🤩
17.02.2025 06:51 — 👍 3 🔁 1 💬 0 📌 0
🤔🤔Ever heard of DMANDs-Disease modifying anti nephropathic drugs
doi.org/10.1093/ndt/...
@hjanders.bsky.social #Nephsky
#Nephpearls
🤩 Looking great in Saree
16.02.2025 12:18 — 👍 1 🔁 0 💬 0 📌 0
The low statin use in CKD is a scandal
It’s a 1A in the guideline but hardly noticed by most - so made it my draft pick www.nephjc.com/freelyfilter... on @freelyfiltered.bsky.social
#Statins4All
#NephSky
🫘Hyperuricemia management in CKD
❌DO NOT use urate lowering drugs in CKD with asymptomatic Hyperuricemia
@nephjc.bsky.social @kdigo.org
#NephPearls #NephSky
🫘Approach to high flow hemodialysis vascular access
#NephSky #Nephpearls
doi.org/10.23876/j.k...
KDIGO: Every CKD patient should be on a statin
KDIGO ADPKD Guidelines
🤗🫘Great insights, inspiring discussions and amazing connections at ISN WCN
@theisn.org @isn-india.bsky.social #ISNWCN
🫘When to do kidney biopsy in diabetes
academic.oup.com/ckj/advance-...
@ckj-era.bsky.social
📝Medical therapy in CKD-RAASi, SGLT2i , GLP1RA and Non steroidal MRA
doi.org/10.1093/ndt/...
@hjanders.bsky.social
😎ADPKD bedside must know questions/pearls
@isn-india.bsky.social social media Team has launched the clinical online bedside series
🎯Sharing some pearls from the first bedside
@arvindcanchi.bsky.social @isn-india.bsky.social
🫘🧬What’s new in Acute kidney injury
Proteomics
Artificial intelligence
And more
doi.org/10.1093/ckj/...
🦠Viral Nephropathies
www.ajkd.org/article/S027...
@ajkd.bsky.social
Do not miss this exciting Bedside clinics in Nephrology series
😎
Not that rare. I would admit that I have also done this form of straightening 🤷♀️😊
25.11.2024 11:47 — 👍 1 🔁 0 💬 1 📌 0
🫘Breaking barriers and gender bias in Nephrology
Interesting read in CJASN by @kidneydoc101.bsky.social
journals.lww.com/cjasn/pages/...
💇♀️Brazilian hair straightening and Oxalate Nephropathy 😱
www.kidney-international.org/article/S008...
